Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

I0775010

Isosorbide mononitrate

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

1,4:3,6-Dianhydro-D-glucitol 5-nitrate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C6H9NO6
Numéro CAS:
16051-77-7
Poids moléculaire :
191.14
Numéro CE :
240-197-2
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

isosorbide

Fabricant/nom de marque

EDQM

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

InChI

1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1

Clé InChI

YWXYYJSYQOXTPL-SLPGGIOYSA-N

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Isosorbide mononitrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

1352008

Isosorbide, United States Pharmacopeia (USP) Reference Standard

1353000

Diluted isosorbide dinitrate (25% mixture with lactose), United States Pharmacopeia (USP) Reference Standard

I0775000

Isosorbide dinitrate, European Pharmacopoeia (EP) Reference Standard

I0775020

Isosorbide 2-nitrate, European Pharmacopoeia (EP) Reference Standard

PHR1486

Isosorbide Solution, Pharmaceutical Secondary Standard; Certified Reference Material

1353102

Diluted Isosorbide Mononitrate, United States Pharmacopeia (USP) Reference Standard

1353113

Diluted Isosorbide Mononitrate Related Compound A, United States Pharmacopeia (USP) Reference Standard

Pictogrammes

Flame
GHS02

Mention d'avertissement

Danger

Mentions de danger

H228

Classification des risques

Flam. Sol. 1

Code de la classe de stockage

4.1A - Other explosive hazardous materials

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

U W Abshagen
The American journal of cardiology, 70(17), 61G-66G (1992-11-27)
Pharmacokinetic studies show that isosorbide mononitrate is rapidly absorbed after oral administration, reaches peak concentrations within an hour, undergoes no significant first-pass metabolism, and is virtually 100% bioavailable. The half-life is approximately 5 hours, the volume of distribution is 0.62
Tiantian Liu et al.
Chinese medicine, 15, 3-3 (2020-01-16)
The Chinese medicine Huoxue Wentong Formula (HXWTF) was used to treat thoracic obstruction and angina pectoris in clinic, which has not been investigated in myocardial ischemia-induced apoptosis and angiogenic function. Here we aimed to investigate the roles of HXWTF in
Francesca Fabrizi et al.
Journal of enzyme inhibition and medicinal chemistry, 27(1), 138-147 (2011-08-06)
The clinically used sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor dorzolamide (DRZ), a new sulfonamide CA inhibitor also incorporating NO-donating moieties, NCX250, and isosorbide mononitrate (ISMN) (an NO-donating compound with no CA inhibitory properties) were investigated for their intraocular pressure
U Thadani et al.
The American journal of cardiology, 70(17), 67G-71G (1992-11-27)
The rapid development of tolerance has limited the applicability of oral and transdermal nitrates in the long-term management of patients with chronic stable angina pectoris. Recent well-controlled trials have demonstrated that asymmetrical, or eccentric, dosing of oral isosorbide mononitrate, in
Athanasios Mousiolis et al.
Contraception, 88(1), 41-44 (2013-01-08)
Isosorbide mononitrate (IMN) administration is thought to enhance in the cervical ripening process. We sought to identify the clinical usefulness and safety of IMN administration for shortening the time to termination of the second trimester pregnancy procedures when used in
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique